Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2016 (2016), Article ID 1504682, 5 pages
http://dx.doi.org/10.1155/2016/1504682
Research Article

An Unprecedented Straightforward Synthesis of Chiral Pyrrolo[3,4-b]quinolone and Pyrrolo[3,2-b]quinolone Backbones Starting from trans-4-Hydroxy-L-proline

Laboratoire de Chimie, URCOM, EA 3221, FR CNRS 3038, Normandie Université, Université du Havre, UFR Sciences et Techniques, 25 rue Philippe Lebon, 76058 Le Havre Cedex, France

Received 2 November 2015; Accepted 29 December 2015

Academic Editor: Marco Radi

Copyright © 2016 Sébastien Comesse and Adam Daïch. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Karthikeyan, C. Lee, J. Moore et al., “IND-2, a pyrimido[1′′,21′′:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells,” Bioorganic & Medicinal Chemistry, vol. 23, no. 3, pp. 602–611, 2015. View at Publisher · View at Google Scholar
  2. D. B. Khadka and W.-J. Cho, “3-Arylisoquinolines as novel topoisomerase i inhibitors,” Bioorganic and Medicinal Chemistry, vol. 19, no. 2, pp. 724–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Pommier, “DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition,” Chemical Reviews, vol. 109, no. 7, pp. 2894–2902, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Cinelli, A. E. Morrell, T. S. Dexheimer et al., “The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode,” Bioorganic and Medicinal Chemistry, vol. 18, no. 15, pp. 5535–5552, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Onyeibor, S. L. Croft, H. I. Dodson et al., “Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action,” Journal of Medicinal Chemistry, vol. 48, no. 7, pp. 2701–2709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. W. Wright, J. Addae-Kyereme, A. G. Breen et al., “Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents,” Journal of Medicinal Chemistry, vol. 44, no. 19, pp. 3187–3194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Bonjean, M. C. De Pauw-Gillet, M. P. Defresne et al., “The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells,” Biochemistry, vol. 37, no. 15, pp. 5136–5146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-J. Kim, M. I. El-Gamal, Y. S. Lee, and C.-H. Oh, “Synthesis and preliminary cytotoxicity evaluation of new diarylamides and diarylureas possessing 2,3-dihydropyrrolo[3,2-b]quinoline scaffold,” Bulletin of the Korean Chemical Society, vol. 34, no. 8, pp. 2480–2486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Pin, S. Comesse, M. Sanselme, and A. Daïch, “A domino N-amidoacylation/aldol-type condensation approach to the synthesis of the topo-I inhibitor rosettacin and derivatives,” Journal of Organic Chemistry, vol. 73, no. 5, pp. 1975–1978, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Pin, S. Comesse, and A. Daïch, “Association of intramolecular furan Diels-Alder reaction and N-acyliminium alkylation for the synthesis of pentacyclic precursor of aromathecins,” Synlett, pp. 3214–3218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. El Blidi, A. Namoune, A. Bridoux et al., “Expeditious synthesis of the topoisomerase I inhibitors isoindolo[2,1-b]isoquinolin-7(5H)-one and the alkaloid rosettacin based on aryl radical cyclization of enamide generated by using N-acyl­iminium chemistry,” Synthesis, vol. 47, no. 22, pp. 3583–3592, 2015. View at Publisher · View at Google Scholar
  12. T. Brunin, L. Legentil, J.-P. Hénichart, and B. Rigo, “Towards new camptothecins. Part 3: synthesis of 5-methoxycarbonyl camptothecin,” Tetrahedron, vol. 62, no. 17, pp. 3959–3968, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Akue-Gedu, P. Gautret, J.-P. Lelieur, and B. Rigo, “An improved synthesis of methyl 1,3-dihydro-2H-pyrrolo[3,4-b]quinoline-2-carboxylate,” Synthesis, no. 21, pp. 3319–3322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-L. Qiu and F.-L. Qing, “Practical synthesis of Boc-protected cis-4-trifluoromethyl and cis-4-difluoromethyl-L- prolines,” Journal of Organic Chemistry, vol. 67, no. 20, pp. 7162–7164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Marco-Contelles, E. Pérez-Mayoral, Abdelouahid Samadi, M. D. C. Carreiras, and E. Soriano, “Recent advances in the Friedländer reaction,” Chemical Reviews, vol. 109, no. 6, pp. 2652–2671, 2009. View at Publisher · View at Google Scholar · View at Scopus